Langley RE, Gilbert DC, Duong T, Clarke NW, et al. Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Lancet 2021;397:581-591.
PMID: 33581820